Douglas C. Lane & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Douglas C. Lane & Associates’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$28M	Sell	407,029 -7,552	-2%	-$499K	0.76%	53
2015 Q3	$24.5M	Sell	414,581 -22,249	-5%	-$1.41M	0.7%	55
2015 Q2	$29.1M	Sell	436,830 -17,891	-4%	-$1.18M	0.78%	54
2015 Q1	$29.3M	Sell	454,721 -10,912	-2%	-$683K	0.77%	54
2014 Q4	$27.5M	Sell	465,633 -3,837	-0.8%	-$216K	0.74%	54
2014 Q3	$24M	Buy	469,470 +1,136	+0.2%	+$56.7K	0.72%	57
2014 Q2	$22.7M	Sell	468,334 -8,170	-2%	-$403K	0.69%	60
2014 Q1	$24.8M	Sell	476,504 -16,702	-3%	-$889K	0.79%	56
2013 Q4	$26.2M	Sell	493,206 -100,881	-17%	-$5.14M	0.87%	49
2013 Q3	$27.5M	Sell	594,087 -88,547	-13%	-$3.89M	1%	40
2013 Q2	$30.5M	Buy	+682,634	New	+$29.6M	1.19%	32

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Douglas C. Lane & Associates's BMY Position: Q4 2015 in Review

Douglas C. Lane & Associates reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q4 2015, selling an estimated $499K and leaving 407,029 shares worth $28M. The position accounts for 0.76% of the portfolio, ranked #53.

Douglas C. Lane & Associates first reported a position in BMY in Q2 2013 and has held it in 11 quarters since. The position peaked at $30.5M in Q2 2013. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Douglas C. Lane & Associates held 407,029 shares of Bristol-Myers Squibb worth $28M as of Q4 2015.
Douglas C. Lane & Associates sold 7,552 Bristol-Myers Squibb shares in Q4 2015, an estimated $499K.
Bristol-Myers Squibb made up 0.76% of Douglas C. Lane & Associates's portfolio in Q4 2015, its #53 holding.
Douglas C. Lane & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 11 quarters since.
Douglas C. Lane & Associates's Bristol-Myers Squibb position peaked at $30.5M in Q2 2013.
1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2015, filed 25 Jan 2016.